British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Starting in September, the UK’s new RSV vaccine program will offer protection across all age groups — find out what this ...

The new respiratory syncytial virus (RSV) vaccines recommended for individuals aged 60 years and older may provide individual and societal cost-savings benefits, a study suggests. 1 "We view this ...

Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season.

Reformulated flu and COVID-19 shots are available to Oregonians starting this month. And an RSV vaccine — developed only last year — could have an unprecedented impact keeping infants out of ...

This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...

With the arrival of new vaccines for respiratory syncytial virus (RSV), Canadian seniors are faced with a critical decision: Is it worth getting the shot, especially if it’s not covered by public ...

COVID-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already ...

Findings showed a noninferior immune response for both vaccines when Shingrix and Arexvy were coadministered compared with separate administration (primary endpoint). Both anti-gE antibody ...